Provided by Tiger Fintech (Singapore) Pte. Ltd.

SITE Centers Corp.

12.74
+0.08000.63%
Post-market: 12.740.00000.00%16:23 EDT
Volume:819.30K
Turnover:10.50M
Market Cap:667.96M
PE:0.93
High:12.98
Open:12.66
Low:12.66
Close:12.66
Loading ...

BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting

GlobeNewswire
·
11 Nov 2024

CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder Cancer

GlobeNewswire
·
11 Nov 2024

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
11 Nov 2024

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer

GlobeNewswire
·
10 Nov 2024

Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME

GlobeNewswire
·
09 Nov 2024

Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting

GlobeNewswire
·
09 Nov 2024

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
08 Nov 2024

Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting

Business Wire
·
08 Nov 2024

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswire
·
08 Nov 2024

Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform

Business Wire
·
08 Nov 2024

Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024

Business Wire
·
08 Nov 2024

Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test

Business Wire
·
08 Nov 2024

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire
·
08 Nov 2024

NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire
·
08 Nov 2024

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024

GlobeNewswire
·
08 Nov 2024

Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update

GlobeNewswire
·
08 Nov 2024